Literature DB >> 1736475

Gangrene and Fournier's gangrene.

R Paty1, A D Smith.   

Abstract

Fournier's gangrene is an aggressive disease affecting the perineum. Clearly, it can no longer by considered idiopathic in its origin, as most infection can be localized to a cutaneous, urethral, or rectal source. It presents in a broad age range and can have an indolent onset, thus requiring a high index of suspicion. It may be fulminant and progressive in the case of immunocompromise and underlying debilitating illnesses. Despite aggressive antibiotic therapy and debridement, it is associated with a high mortality rate. This rate has been higher in older patients, those with a rectal focus, and diabetics. Hyperbaric oxygen therapy has shown some promise in shortening hospital stays, increasing wound healing, and decreasing the gangrenous spread when used in conjunction with surgical debridement and antibiotics. New reconstructive efforts, such as medial thigh myocutaneous flaps, have improved the cosmetic aftermath of the extensive debridement. Fournier's gangrene remains a true urologic emergency, which mandates aggressive initial care by means of early recognition, early hemodynamic stabilization, and the institution of parenteral broad-spectrum antibiotics. This is followed by multiple debridements and in some cases urinary or rectal diversion. The concomitant use of hyperbaric oxygen therapy in selected cases followed by meticulous reconstructive surgery and salvage has further reduced the mortality rate and improved the cosmetic outcome.

Entities:  

Mesh:

Year:  1992        PMID: 1736475

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  42 in total

1.  Fournier's gangrene: can aggressive treatment save life?

Authors:  J Fillo; I Cervenakov; P Labas; J Mardiak; K Szoldová; M Kopecný; S Szeiff; M Mal'a; D Chovan
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  Role of mebo (moist exposed burn ointment) in the treatment of fournier's gangrene.

Authors:  M Al-Meshaan; M Abdul Hamid; T Quider; A Al-Sairafi; R Dham
Journal:  Ann Burns Fire Disasters       Date:  2008-03-31

3.  Fournier's ganrene in the HIV era.

Authors:  Peter Ngugi; George Magoha; Paul Nyaga
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

4.  CT findings of perforated rectal carcinoma presenting as Fournier's gangrene in the emergency department.

Authors:  Lorraine Ash; Jonathan Hale
Journal:  Emerg Radiol       Date:  2005-06-03

Review 5.  Fournier's gangrene and its emergency management.

Authors:  A Thwaini; A Khan; A Malik; J Cherian; J Barua; I Shergill; K Mammen
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

6.  Unusual cause of acute scrotal cellulitis in an HIV positive man.

Authors:  K G Yoganathan; A L Blackwell
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

Review 7.  Necrotising fasciitis: a new management algorithm based on clinical classification.

Authors:  Paul S Carter; Paul E Banwell
Journal:  Int Wound J       Date:  2004-09       Impact factor: 3.315

8.  Fournier gangrene as a manifestation of undiagnosed metastatic perforated colorectal cancer.

Authors:  Cyrus C Chan; Mallory Williams
Journal:  Int Surg       Date:  2013 Jan-Mar

9.  Management of equivocal (early) Fournier's gangrene.

Authors:  Mohamed El-Shazly; Mohamed Aziz; Hamdy Aboutaleb; Shady Salem; Eid El-Sherif; Mohamed Selim; Mohamed Sultan; Mohamed Omar; Tarek Abd Elbaky; Fouad Zanaty; Talal Alenezi; Abdelazeem Ghobashi; Adel Allam
Journal:  Ther Adv Urol       Date:  2016-06-28

10.  The clinical features of Fournier's gangrene and the predictivity of the Fournier's Gangrene Severity Index on the outcomes.

Authors:  Sahin Kabay; Mehmet Yucel; Faik Yaylak; Mustafa C Algin; Alper Hacioglu; Burhan Kabay; Ahmet Y Muslumanoglu
Journal:  Int Urol Nephrol       Date:  2008-06-19       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.